Loading company profile …

Pricing Privacy Cookies

SERCA PHARMACEUTICALS AS

← Back to search

SERCA PHARMACEUTICALS AS

Org.nr. 921 663 846 · Private limited company (AS) · OSLO

Analyze

Key figures 2025

Revenue

NOK 3m

▼ 37.2%

Operating profit

NOK 10.8k

▲ 100.7%

Net profit

NOK 131.8k

▲ 111.4%

Equity

NOK 27.9m

▲ 0.9%

Employees: Not registered
Revenue per employee: Cannot be calculated
Operating margin: 0.4%
Age: 8 years

Source: Regnskapsregisteret (Brønnøysundregistrene) · Fetched 27/10/2026, 03:40

Creating the analysis …

Key information

Chief executive

Financial health 2025

Profitability

Not satisfactory

Solidity

69.3%

Very good

Liquidity

Roles

General manager: Kjetil Hestdal (b. 1960) – General manager
Board: Erlend Petter Skagseth (b. 1955) – Chair of the board
Kristin Sandereid (b. 1968) – Board member
Jens Halvard Grønlien (b. 1974) – Board member
Jonas Hallén (b. 1978) – Board member
Auditor: UNIC REVISJON AS – Auditor
Accountant: STATEMENT AS – Accountant

Person profiles with every company a person has roles in are coming soon.

Source: Enhetsregisteret (Brønnøysundregistrene) · Fetched 27/10/2026, 03:40

People

People with roles in this company, and the other companies they have roles in.

Erlend Petter Skagseth (b. 1955)
Here: Chair of the board
Also has roles in

Kjetil Hestdal (b. 1960)

Industry

72.100 Forskning og eksperimentell utvikling innenfor naturvitenskap og teknikk

Address

Gaustadalléen 21, 0349 OSLO

Employees

Not registered

Founded

8 October 2018

Website

Not registered

Contact details

Not registered

Auditor

UNIC REVISJON AS

Accountant

STATEMENT AS

Purpose / activity (in Norwegian)

Utvikle, markedsføre og selge medisinske produkter og utstyr, samt det som står i forbindelse med dette.

More company details

Organisation number: 921 663 846
Legal form: Private limited company (AS) (AS)
Registered in the Central Coordinating Register: 7 November 2018
Sector: Private aksjeselskaper mv.
VAT register: Registered
Register of Business Enterprises: Registered
Latest annual accounts filed: 2025
Business address: Gaustadalléen 21, 0349 OSLO
Postal address: Postboks 8600 Majorstuen, 0349 OSLO
Municipality: OSLO

Source: Enhetsregisteret (Brønnøysundregistrene) · Fetched 27/10/2026, 03:40

3.23

Very good

Accounts

Operating revenue

NOK 3m▼ 37.2%

3.6M

2023

4.7M

2024

2025

Operating profit

NOK 10.8k▲ 100.7%

−4.4M

2023

−1.5M

2024

11k

2025

Net profit

NOK 131.8k▲ 111.4%

−4.4M

2023

−1.2M

2024

132k

2025

Equity

NOK 27.9m▲ 0.9%

16.4M

2023

27.6M

2024

27.9M

2025

Total assets

NOK 40.2m▼ 1%

17.9M

2023

40.6M

2024

40.2M

2025

Total liabilities

NOK 12.3m▼ 5%

1.5M

2023

13M

2024

12.3M

2025

Source: Regnskapsregisteret (Brønnøysundregistrene) · Fetched 27/10/2026, 03:40

SARSIA SEED AS

General manager

›

Jens Halvard Grønlien (b. 1974)

Here: Board member

Also has roles in

NANSEN NEUROSCIENCE NETWORKBoard member

Jonas Hallén (b. 1978)

Here: Board member

Also has roles in

ADEN ASChair of the board
ARXX THERAPEUTICS ASBoard member
NADENO NANOSCIENCE ASBoard member

Kjetil Hestdal (b. 1960)

Here: General manager

Also has roles in

AKIGAI ASBoard member
AUGERE MEDICAL ASBoard member
CAEDO ONCOLOGY ASGeneral manager
K OG K ASChair of the board
NILSEHOVDA VELFORENINGChair of the board

Kristin Sandereid (b. 1968)

Here: Board member

Also has roles in

DHEALTH ASChair of the board
NORAMBER ASGeneral manager
SANDEREID ENKOwner

Companies

No companies are connected to this entity through roles.

Owners (shareholders) are not in the business register but in the Norwegian Tax Administration's shareholder register. Coming later.

People are matched on name and date of birth from the register, never on name alone. Source: Register of roles (Brønnøysundregistrene) · Fetched 25/10/2026, 22:59